Cargando…

The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum

AIM: The purpose of this qualitative study was to investigate the effects experienced by users of a novel psychoactive substance, the benzodiazepine flubromazolam, by analysing users’ own accounts on the Swedish forum Flashback.org. METHOD: A thematic analysis of anonymous self-reports published on...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Martin, Kjellgren, Anette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450873/
https://www.ncbi.nlm.nih.gov/pubmed/32934486
http://dx.doi.org/10.1177/1455072517706304
_version_ 1783574878720360448
author Andersson, Martin
Kjellgren, Anette
author_facet Andersson, Martin
Kjellgren, Anette
author_sort Andersson, Martin
collection PubMed
description AIM: The purpose of this qualitative study was to investigate the effects experienced by users of a novel psychoactive substance, the benzodiazepine flubromazolam, by analysing users’ own accounts on the Swedish forum Flashback.org. METHOD: A thematic analysis of anonymous self-reports published on the forum was performed and generated five general themes describing effects and experiences by flubromazolam users. RESULTS: The themes which emerged were: Onset and duration, Desired effects, Adverse effects and addiction, Loss of control, General estimations and evaluations. The main reported characteristics of flubromazolam were heavy hypnotic and sedative effects, long-lasting amnesiac effects and the rapid development of tolerance. Flubromazolam was also anxiolytic and acted as a muscle relaxant for many users. Some users experienced euphoria or intense wellbeing. Other prominent characteristics were loss of control (leading to poor choices and actions, with unpleasant consequences) and long-lasting, often severe withdrawals. There were also serious incidents where users had been admitted to hospital, acute psychiatric treatment or taken into custody by the police. CONCLUSION: Flubromazolam appears to be a highly addictive and precarious benzodiazepine with many, possibly severe, side effects. The substance is generally described as very potent and with long-lasting effects. Memory loss and loss of control are common adverse effects, and withdrawals appear to be severe for many users.
format Online
Article
Text
id pubmed-7450873
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74508732020-09-14 The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum Andersson, Martin Kjellgren, Anette Nordisk Alkohol Nark Research Reports AIM: The purpose of this qualitative study was to investigate the effects experienced by users of a novel psychoactive substance, the benzodiazepine flubromazolam, by analysing users’ own accounts on the Swedish forum Flashback.org. METHOD: A thematic analysis of anonymous self-reports published on the forum was performed and generated five general themes describing effects and experiences by flubromazolam users. RESULTS: The themes which emerged were: Onset and duration, Desired effects, Adverse effects and addiction, Loss of control, General estimations and evaluations. The main reported characteristics of flubromazolam were heavy hypnotic and sedative effects, long-lasting amnesiac effects and the rapid development of tolerance. Flubromazolam was also anxiolytic and acted as a muscle relaxant for many users. Some users experienced euphoria or intense wellbeing. Other prominent characteristics were loss of control (leading to poor choices and actions, with unpleasant consequences) and long-lasting, often severe withdrawals. There were also serious incidents where users had been admitted to hospital, acute psychiatric treatment or taken into custody by the police. CONCLUSION: Flubromazolam appears to be a highly addictive and precarious benzodiazepine with many, possibly severe, side effects. The substance is generally described as very potent and with long-lasting effects. Memory loss and loss of control are common adverse effects, and withdrawals appear to be severe for many users. SAGE Publications 2017-05-16 2017-06 /pmc/articles/PMC7450873/ /pubmed/32934486 http://dx.doi.org/10.1177/1455072517706304 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Reports
Andersson, Martin
Kjellgren, Anette
The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
title The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
title_full The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
title_fullStr The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
title_full_unstemmed The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
title_short The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum
title_sort slippery slope of flubromazolam: experiences of a novel psychoactive benzodiazepine as discussed on a swedish online forum
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450873/
https://www.ncbi.nlm.nih.gov/pubmed/32934486
http://dx.doi.org/10.1177/1455072517706304
work_keys_str_mv AT anderssonmartin theslipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum
AT kjellgrenanette theslipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum
AT anderssonmartin slipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum
AT kjellgrenanette slipperyslopeofflubromazolamexperiencesofanovelpsychoactivebenzodiazepineasdiscussedonaswedishonlineforum